Pindolol in hypertension: a double-blind trial. 1972

P M Feltham, and O F Watson, and J S Peel, and D J Dunlop, and A S Turner

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010869 Pindolol A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638) Prindolol,LB-46,Visken,LB 46,LB46
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011187 Posture The position or physical attitude of the body. Postures
D001769 Blood The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females

Related Publications

P M Feltham, and O F Watson, and J S Peel, and D J Dunlop, and A S Turner
June 1982, Irish medical journal,
P M Feltham, and O F Watson, and J S Peel, and D J Dunlop, and A S Turner
March 1976, Revista medica de Chile,
P M Feltham, and O F Watson, and J S Peel, and D J Dunlop, and A S Turner
September 1972, The New Zealand medical journal,
P M Feltham, and O F Watson, and J S Peel, and D J Dunlop, and A S Turner
July 1975, JPMA. The Journal of the Pakistan Medical Association,
P M Feltham, and O F Watson, and J S Peel, and D J Dunlop, and A S Turner
August 1974, The New Zealand medical journal,
P M Feltham, and O F Watson, and J S Peel, and D J Dunlop, and A S Turner
May 2000, European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,
P M Feltham, and O F Watson, and J S Peel, and D J Dunlop, and A S Turner
January 1984, European journal of clinical pharmacology,
P M Feltham, and O F Watson, and J S Peel, and D J Dunlop, and A S Turner
October 2000, Journal of clinical psychopharmacology,
P M Feltham, and O F Watson, and J S Peel, and D J Dunlop, and A S Turner
April 1979, British journal of clinical pharmacology,
P M Feltham, and O F Watson, and J S Peel, and D J Dunlop, and A S Turner
January 1979, British journal of clinical pharmacology,
Copied contents to your clipboard!